Corrigendum to: Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies. . Inflamm Bowel Dis 2021 Jan 29. pii: 6123652. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Corrigendum to: Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies. Inflamm Bowel Dis 2021 Jan 29. pii: 6123652. doi: 10.1093.
PMID: 33511983